REVIEW
|
doi:10.20944/preprints202402.0668.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Myelodysplastic neoplasm; myelodysplastic syndrome; MDS; precision medicine; targeted therapy
Online: 12 February 2024 (10:29:30 CET)
REVIEW
|
doi:10.20944/preprints202406.1958.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
mesenchymal stem cells; leukaemia; bone marrow microenvironment; myelodysplastic syndromes
Online: 1 July 2024 (10:58:13 CEST)
REVIEW
|
doi:10.20944/preprints202311.0772.v1
Subject:
Medicine And Pharmacology,
Dermatology
Keywords:
myelodysplastic and myeloproliferative neoplasms; CMML; skin
Online: 13 November 2023 (08:37:06 CET)
ARTICLE
|
doi:10.20944/preprints202112.0137.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
myelodysplastic syndrome (MDS); oxidative stress; cytokines; inflammation; 5-Azacitidine; somatic alterations
Online: 8 December 2021 (14:36:28 CET)
ARTICLE
|
doi:10.20944/preprints202403.0042.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Hematopoietic stem and progenitor cell (HSPC); acute myeloid leukemia (AML); Myelodysplastic syndromes (MDS); leukemic stem cell (LSC) CD34; CD38; CD45RA; CD123; PD-L1; flow cytometry; t-SNE; high-dimensional space analyses; classification; dimensionality reduction; immunophenotyping
Online: 4 March 2024 (01:30:54 CET)
ARTICLE
|
doi:10.20944/preprints202402.1079.v2
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Myelodysplastic syndrome (MDS); Metabolism; DNA Methylation; DNMT3A; TET2
Online: 22 February 2024 (11:39:16 CET)
ARTICLE
|
doi:10.20944/preprints202201.0292.v2
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Cancer biomarker; Proteomic analysis; Myelodysplastic syndromes; Frutalin; MDS-RS; MDS-EB
Online: 24 January 2022 (10:53:36 CET)
ARTICLE
|
doi:10.20944/preprints202309.1338.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
iron chelation; iron overload; myelodysplastic syndromes; MDS; myeloproliferative neoplasms; MPN; ferritin; hematologic improvement
Online: 20 September 2023 (05:39:06 CEST)
ARTICLE
|
doi:10.20944/preprints202401.1554.v1
Subject:
Engineering,
Bioengineering
Keywords:
myelodysplastic syndromes (MDS); interferometric phase microscopy (IPM); hematology
Online: 22 January 2024 (09:47:44 CET)
REVIEW
|
doi:10.20944/preprints202403.1779.v1
Subject:
Biology And Life Sciences,
Life Sciences
Keywords:
nucleus; phosphoinositides; pholipases C; myelodysplastic neoplasm (MDS); muscle; brain
Online: 28 March 2024 (14:29:15 CET)
REVIEW
|
doi:10.20944/preprints202309.2129.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Immune thrombocytopenia; chronic ITP; myelodysplastic syndrome; chronic myelomonocytic leukemia; refractory thrombocytopenia
Online: 30 September 2023 (07:14:13 CEST)
ARTICLE
|
doi:10.20944/preprints202104.0087.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Myelodysplastic syndrome; Positron Emission Tomography; [18F]fluoro-thymidine; small animal imaging
Online: 5 April 2021 (10:14:33 CEST)
ARTICLE
|
doi:10.20944/preprints202402.1510.v1
Subject:
Medicine And Pharmacology,
Pediatrics, Perinatology And Child Health
Keywords:
myelodysplastic syndrome (MDS); microRNAs (miRNs); oxidative stress; inflammatory cytokines; 5-azacitidine (5-AZA)
Online: 27 February 2024 (10:12:07 CET)
REVIEW
|
doi:10.20944/preprints202308.1982.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
myelodysplastic syndromes; non-coding RNA; microRNA; lnc-RNA; circ-RNA; piwi-RNA; t-RNA; sno-RNA
Online: 29 August 2023 (13:42:14 CEST)
REVIEW
|
doi:10.20944/preprints202406.0537.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
CRISPR-Cas; gene editing; gene therapy; hematology; inherited germline predisposition to cancer; bone marrow failure; acute myeloid leukemia; myelodysplastic syndromes; myeloid neoplasms; DNA repair
Online: 10 June 2024 (08:39:04 CEST)
REVIEW
|
doi:10.20944/preprints202201.0366.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
cell-free DNA; liquid biopsy; cancer; next-generation sequencing (NGS); minimal residual disease; measurable residual disease; molecular residual disease (MRD); leukemia; lymphoma; myeloma; myeloproliferative neoplasms; myelodysplastic syndrome
Online: 25 January 2022 (08:13:24 CET)